iRadimed Corporation (IRMD) vs PROCEPT BioRobotics Corporation (PRCT)
- iRadimed Corporation IRMD 84.37 −1.37%
- PROCEPT BioRobotics Corporation PRCT 20.49 +1.09%
iRadimed Corporation and PROCEPT BioRobotics Corporation are both Medical Devices companies. iRadimed Corporation and PROCEPT BioRobotics Corporation are of similar size ($1.2B and $1.1B). PROCEPT BioRobotics Corporation has negative trailing earnings, so its P/E is not meaningful; iRadimed Corporation trades at 44.9×. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 17.5% against 11.0%. iRadimed Corporation has the higher net margin (26.9% vs −32.6%) and the higher return on invested capital (41.8% vs −45.6%). Across the 19 metrics below, iRadimed Corporation leads on 14 and PROCEPT BioRobotics Corporation on 5.
Valuation
Profitability
| Metric | IRMD | PRCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 75.51% | 64.66% | 57.76% |
| Operating margin | 32.30% | (33.61%) | (15.07%) |
| Net margin | 26.85% | (32.60%) | (14.45%) |
| Free cash flow margin | 28.66% | (24.15%) | (3.88%) |
| Return on equity | 23.42% | (32.39%) | (10.35%) |
| Return on assets | 20.34% | (23.31%) | (17.26%) |
| Return on invested capital | 41.79% | (45.60%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack